Butoconazole is an imidazole antifungal agent used primarily to treat vaginal yeast infections caused by Candida species. As a potent azole medication, it functions by inhibiting fungal cytochrome P450… Read more


![Chemical structure of 1-[2-Chloro-4-(4-chlorophenyl)butyl]-1H-imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F67085-12-5-1-2-Chloro-4-4-chlorophenylbutyl-1H-imidazole.png&w=3840&q=75)











![Chemical structure of α-[2-(4-Chlorophenyl)ethyl]-1H-imidazole-1-ethanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F67085-11-4-2-4-Chlorophenylethyl-1H-imidazole-1-ethanol.png&w=3840&q=75)
Butoconazole is an imidazole antifungal agent used primarily to treat vaginal yeast infections caused by Candida species. As a potent azole medication, it functions by inhibiting fungal cytochrome P450 enzymes, which are essential for the synthesis of ergosterol, a critical component of the fungal cell membrane. Laboratories working with this active pharmaceutical ingredient require high-quality reference standards for accurate analytical assessment and regulatory compliance. The comprehensive selection provided here includes the parent drug alongside its related impurities and metabolites. These compounds serve as vital tools for pharmaceutical chemists performing routine quality control, impurity profiling, and method validation to ensure the efficacy and safety of antifungal formulations. By utilizing these characterized reference materials, researchers can reliably detect, identify, and quantify specific substances during development and stability studies to maintain rigorous pharmacopeial and quality standards.